Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RaQualia Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
RaQualia Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 9
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
RaQualia Pharma to Form Joint Venture with ZTE Biotech 11
RaQualia Pharma Enters into Agreement with Takeda Pharma 12
Sihuan Pharma Enters into Agreement with RaQualia Pharma 13
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 14
RaQualia Pharma Enters Into Research Agreement With Asahi Kasei Pharma 15
RaQualia Pharma Enters Into Research Agreement With Interprotein For PPI Inhibitor 16
RaQualia Pharma Enters into Research Agreement with Ajinomoto Pharma 17
Licensing Agreements 18
NewBay Medical Enters into Licensing Agreement with AskAt 18
Maruho Enters into Licensing Agreement with RaQualia Pharma 19
AskAt Enters into Licensing Agreement with Arrys Therapeutics 20
Ningbo Tai Kang Medical Enters into Licensing Agreement with AskAt 21
RMX Pharma Enters into Licensing Agreement with AskAt 22
Syros Pharma Amends Licensing Agreement with TMRC 23
TMRC Enters Into Licensing Agreement with Ohara Pharmaceutical 24
AskAt Receives Intellectual Property from RaQualia Pharma 25
Equity Offering 26
RaQualia Pharma Raises Funds through Private Placement of Shares upon Exercise of Warrants 26
RaQualia Pharma Raises Funds through Private Placement of Shares upon Exercise of Warrants 27
RaQualia Pharma Inc – Key Competitors 28
RaQualia Pharma Inc – Key Employees 29
RaQualia Pharma Inc – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Product News 31
07/19/2018: Investigational New Drug (IND) Application for EP4 antagonist AAT-007 for Oncology Is Approved in China 31
07/09/2018: Takeda completes the evaluation of RaQualia’s compound 32
07/06/2018: RaQualia Announces Receipt of Milestone Payment from CJ HealthCare 33
Product Approvals 34
Jan 22, 2018: Investigational New Drug (IND) Application for EP4 antagonist AAT-007 for Oncology Filed in China 34
Dec 18, 2017: Investigational new drug application for EP4 antagonist AAT-007 was approved by the National Food and Drug Administration of the People’s Republic of China 35
Appendix 36
Methodology 36
About GlobalData 36
Contact Us 36
Disclaimer 36
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RaQualia Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RaQualia Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
RaQualia Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 9
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
RaQualia Pharma to Form Joint Venture with ZTE Biotech 11
RaQualia Pharma Enters into Agreement with Takeda Pharma 12
Sihuan Pharma Enters into Agreement with RaQualia Pharma 13
RaQualia Pharma Enters into Research Agreement with XuanZhu Pharma 14
RaQualia Pharma Enters Into Research Agreement With Asahi Kasei Pharma 15
RaQualia Pharma Enters Into Research Agreement With Interprotein For PPI Inhibitor 16
RaQualia Pharma Enters into Research Agreement with Ajinomoto Pharma 17
NewBay Medical Enters into Licensing Agreement with AskAt 18
Maruho Enters into Licensing Agreement with RaQualia Pharma 19
AskAt Enters into Licensing Agreement with Arrys Therapeutics 20
Ningbo Tai Kang Medical Enters into Licensing Agreement with AskAt 21
RMX Pharma Enters into Licensing Agreement with AskAt 22
Syros Pharma Amends Licensing Agreement with TMRC 23
TMRC Enters Into Licensing Agreement with Ohara Pharmaceutical 24
AskAt Receives Intellectual Property from RaQualia Pharma 25
RaQualia Pharma Raises Funds through Private Placement of Shares upon Exercise of Warrants 26
RaQualia Pharma Raises Funds through Private Placement of Shares upon Exercise of Warrants 27
RaQualia Pharma Inc, Key Competitors 28
RaQualia Pharma Inc, Key Employees 29
RaQualia Pharma Inc, Other Locations 30
RaQualia Pharma Inc, Subsidiaries 30
List of Figures
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
RaQualia Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
RaQualia Pharma Inc, Medical Devices Deals, 2012 to YTD 2018 9